title: Effect of protein kinase C activation on the glycine evoked Cl(-) current in spinal cord neurons.
abstract: We investigated whether the effect of phorbol-12-myristate-13-acetate (PMA) was altered by a kinase inhibitor and by down-regulation of protein kinase C (PKC) in order to determine if glycine receptors in mouse spinal neurons, unlike those in hippocampal and trigeminal neurons, can be inhibited by PKC. To examine the above, electrophysiological and immunofluorescence studies were carried out in mouse spinal neurons kept in culture for up to 3 weeks. The inhibition of the glycine activated current by PMA (1 microM) increased from 12+/-3% during week 1 to 27+/-6% during week 3. The effect of PMA was completely blocked by the PKC selective inhibitor RO 31-8220 (1 microM). After culturing the cells with 1 microM PMA for 24 h, the inhibitory effect of acute application of PMA disappeared altogether, suggesting that the effect of PMA was via PKC. Immunofluorescence studies showed that a short stimulation with PMA translocated the enzyme to the periphery whereas longer term stimulation (24 h) down regulated the PKC signal. These results indicate that activation of PKC by PMA inhibits the glycine receptor in cultured spinal neurons and that its sensitivity changes during neuronal development.
authors.affiliation: Laboratory of Neurophysiology, Department of Physiology, P.O. Box 160-C, University of Concepcion, Chile.
authors.forename: F A
authors.initials: FA
authors.lastname: Albarran
authors.forename: J P
authors.initials: JP
authors.lastname: Roa
authors.forename: R
authors.initials: R
authors.lastname: Navarrete
authors.forename: R
authors.initials: R
authors.lastname: Castillo
authors.forename: F
authors.initials: F
authors.lastname: Nualart
authors.forename: L G
authors.initials: LG
authors.lastname: Aguayo
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D018118:Chloride Channels / Q000187:drug effects* / Q000378:metabolism; D002712:Chlorides / Q000378:metabolism*; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D005998:Glycine / Q000494:pharmacology*; D007211:Indoles / Q000494:pharmacology*; D017136:Ion Transport / Q000187:drug effects* / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D009419:Nerve Tissue Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D018408:Patch-Clamp Techniques; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D018009:Receptors, Glycine / Q000187:drug effects* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013116:Spinal Cord / Q000166:cytology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
chemical_list: D018118:Chloride Channels; D002712:Chlorides; D004791:Enzyme Inhibitors; D007211:Indoles; D009419:Nerve Tissue Proteins; D018009:Receptors, Glycine; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate; D005998:Glycine; C064758:Ro 31-8220